Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages

AIDS

Volumn 14, Issue 12, 2000, Pages 1739-1748

  Kedzierska, Katherine ^a,c   Maerz, Anne ^a,c   Warby, Tammra ^a   Jaworowski, Anthony ^a,c   Chan, HiuTat ^a   Mak, Johnson ^a   Sonza, Secondo ^a   Lopez, Angel ^b,c   Crowe, Suzanne ^a,c  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b Matthew Roberts Laboratory   (Australia)

^c National Centre for HIV Virology Research   (Australia)

Author keywords

GM CSF; Granulocyte macrophage colony stimulating factor; HIV; Macrophage; Replication

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; MESSENGER RNA; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; VIRUS REPLICATION;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENES, GAG; GRANULOCYTE COLONY-STIMULATING FACTOR; HIV CORE PROTEIN P24; HIV-1; MACROPHAGES; MONOCYTES; RNA, MESSENGER; VIRUS REPLICATION;

EID: 0033827554     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200008180-00008     Document Type: Article

References (52)

1. The role of mononuclear phagocytes in HTLVIII/LAV infection
2. Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages
3. Infection of monocyte-macrophages by human T lymphotropic virus type III
4. Infection of monocyte-derived macrophages with human immunodeficieney virus type 1 (HIV-1). Monocyte tropic and lymphocyte tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types
5. Human T lymphotropic virus type III infection of human alveolar macrophages
6. Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages
7. CC CKR5: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage tropic HIV-1
8. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)
9. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes
10. Enhanced HIV replication in macrophage colony stimulating factor treated monocytes
11. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1 treated monocytes
12. Tumor necrosis factor alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages
13. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro
14. Cytokines alter production of HIV-1 from primary mononuclear phagocytes
15. Effect of GM-CSF on HIV-1 replication in monocytes/macrophages in vivo and in vitro: A review
16. C-C chemokines released by lipopolysaccharide (LPS) stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells
17. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages
18. Hemopoietic regulators
19. Emerging applications of recombinant human grranulocyte-macrophage colony stimulating factor
20. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3 x-azido-2x3x-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine
21. Induction of monocyte proliferation and HIV expression by IL-3 does not interfere with anti-viral activity of zidovudine
22. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocytes/macrophages
23. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macropohages through modulation of CCR5 expression
24. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
25. Lipopolysaccharide is a potent monocyte/macrophage specific stimulator of human immunodeficiency virus type 1 expression
26. Effect of zidovudine and granulocyte-macrophage colony stimulating factor on human immunodeficiency virus replication in alveolar macrophages
27. Suppression of HIV replication in human monocyte derived macrophages induced by granulocyte macrophage colony stimulating factor
28. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages
29. GM-CSF and its effects on replication of HIV-1 in cells of macrophage lineage
30. Residue 21 of human granulocyte macrophage colony stimulating factor is critical for biological activity and for high but not low affinity binding
31. Identification of residues in the first and fourth helices of human granulocyte macrophage colony stimulating factor involved in biologic activity and in binding to the alpha and beta chains of its receptor
32. The human granulocyte macrophage colony stimulating factor (GM-CSF) receptor exists as a preformed receptor complex that can be activated by GM-CSF, interleukin-3, or interleukin-5
33. Quantitative assessment of HIV-1 DNA load by coamplification of HIV-1 gag and HLA-DQ-alpha genes
34. Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction
35. Susceptibility of human monocytes to HIV-1 infection in vitro is not dependent on their level of CD4 expression
36. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1
37. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection
38. Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages
39. CD4, CXCR-4, and CCR5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1
40. Interferon-γ upregulates CCR5 expression in cord and adult blood mononuclear phagocytes
41. Expression cloning of a receptor for human granulocyte macrophage colony stimulating factor
42. Structural design and molecular evolution of a cytokine receptor superfamily
43. Expression and function of the human granulocyte macrophage colony stimulating factor receptor alpha subunit
44. Clinical and virological effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodkin's lymphoma: Results of randomized trial
45. GM-CSF increases HIV-1 load
46. GM-CSF augments phagocytosis of Mycobacterium avium complex by HIV-1 infected monocytes/macrophages in vitro and in vivo
47. Interferon-alpha, zidovudine and granulocyte macrophage colony stimulating factor; a phase I AIDS clinical trials group study in patients with Kaposi's Sarcoma associated with AIDS
48. Initial clinical experience with dideoxynucleosides as single agents and in combination therapy
49. Safety of GM-CSF in patients with AIDS: A review of the literature
50. Granulocyte macrophage colony stimulating factor (GM-CSF) reduces viral load and increases CD4 cell counts in individuals with AIDS receiving AZT
51. The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: A randomized double blind, placebo-controlled trial
52. Potential utility of recombinant human GM-CSF as adjunctive treatment of refractory oropharyngeal candidiasis in AIDS patients